These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Introduction: The ecological relevance of chemically induced endocrine disruption in wildlife. Jobling S; Tyler CR Environ Health Perspect; 2006 Apr; 114 Suppl 1(Suppl 1):7-8. PubMed ID: 16818239 [No Abstract] [Full Text] [Related]
8. The endocrine disrupters: a major medical challenge. Amaral Mendes JJ Food Chem Toxicol; 2002 Jun; 40(6):781-8. PubMed ID: 11983272 [TBL] [Abstract][Full Text] [Related]
9. Proceedings of the 5th Copenhagen Workshop on Endocrine Disrupters: Ubiquitous endocrine disrupters and possible human health effects, 20-22 May 2009. Int J Androl; 2010 Apr; 33(2):251-474. PubMed ID: 20806455 [No Abstract] [Full Text] [Related]
10. Proceedings of the 5th Copenhagen Workshop on endocrine disrupters: ubiquitous endocrine disrupters and possible human health effects. Preface. Andersson AM; Bay K; Grigor KM; Toppari J; Skakkebaek NE Int J Androl; 2010 Apr; 33(2):251. PubMed ID: 20487041 [No Abstract] [Full Text] [Related]
11. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations". Marty S Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782 [No Abstract] [Full Text] [Related]
13. Receptors mediating toxicity and their involvement in endocrine disruption. Rüegg J; Penttinen-Damdimopoulou P; Mäkelä S; Pongratz I; Gustafsson JA EXS; 2009; 99():289-323. PubMed ID: 19157066 [TBL] [Abstract][Full Text] [Related]
14. The effects of nanomaterials as endocrine disruptors. Iavicoli I; Fontana L; Leso V; Bergamaschi A Int J Mol Sci; 2013 Aug; 14(8):16732-801. PubMed ID: 23949635 [TBL] [Abstract][Full Text] [Related]
15. Dose-response relationships for endocrine disruptors: what we know and what we don't know. Lucier GW Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):34-5. PubMed ID: 9339476 [No Abstract] [Full Text] [Related]
16. Endocrine disruption: historical perspectives and its impact on the future of toxicology testing. Marty MS; Carney EW; Rowlands JC Toxicol Sci; 2011 Mar; 120 Suppl 1():S93-108. PubMed ID: 20974704 [No Abstract] [Full Text] [Related]
17. What are the health concerns about BPA? Mayo Clin Womens Healthsource; 2010 Jul; 14(7):8. PubMed ID: 20517192 [No Abstract] [Full Text] [Related]
18. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program. Borgert CJ; Mihaich EM; Ortego LS; Bentley KS; Holmes CM; Levine SL; Becker RA Regul Toxicol Pharmacol; 2011 Nov; 61(2):185-91. PubMed ID: 21803110 [TBL] [Abstract][Full Text] [Related]
19. Introduction--workshop on characterizing the effects of endocrine disruptors on human health at environmental exposure levels. Melnick RL Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):603-4. PubMed ID: 10421769 [TBL] [Abstract][Full Text] [Related]
20. The impact of endocrine disruptors on endocrine targets. Diamanti-Kandarakis E; Palioura E; Kandarakis SA; Koutsilieris M Horm Metab Res; 2010 Jul; 42(8):543-52. PubMed ID: 20419622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]